Cefepime-induced encephalopathy in patients with renal failure
ENCEFALOPATÍA POR CEFEPIMA EN PACIENTES CON INSUFICIENCIA RENAL.
Read
10178
Timeswas read the article
2180
Total PDF
7998
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 40 | 6 | 46 |
| 2025 5 | 231 | 42 | 273 |
| 2025 4 | 266 | 28 | 294 |
| 2025 3 | 344 | 58 | 402 |
| 2025 2 | 180 | 30 | 210 |
| 2025 1 | 140 | 57 | 197 |
| 2024 12 | 106 | 29 | 135 |
| 2024 11 | 89 | 35 | 124 |
| 2024 10 | 71 | 30 | 101 |
| 2024 9 | 77 | 25 | 102 |
| 2024 8 | 99 | 46 | 145 |
| 2024 7 | 72 | 27 | 99 |
| 2024 6 | 103 | 38 | 141 |
| 2024 5 | 70 | 38 | 108 |
| 2024 4 | 65 | 22 | 87 |
| 2024 3 | 70 | 27 | 97 |
| 2024 2 | 73 | 30 | 103 |
| 2024 1 | 56 | 35 | 91 |
| 2023 12 | 52 | 24 | 76 |
| 2023 11 | 69 | 28 | 97 |
| 2023 10 | 94 | 36 | 130 |
| 2023 9 | 98 | 26 | 124 |
| 2023 8 | 80 | 26 | 106 |
| 2023 7 | 85 | 24 | 109 |
| 2023 6 | 117 | 17 | 134 |
| 2023 5 | 85 | 33 | 118 |
| 2023 4 | 79 | 13 | 92 |
| 2023 3 | 82 | 22 | 104 |
| 2023 2 | 62 | 18 | 80 |
| 2023 1 | 64 | 18 | 82 |
| 2022 12 | 85 | 27 | 112 |
| 2022 11 | 103 | 25 | 128 |
| 2022 10 | 81 | 27 | 108 |
| 2022 9 | 66 | 27 | 93 |
| 2022 8 | 170 | 41 | 211 |
| 2022 7 | 99 | 36 | 135 |
| 2022 6 | 72 | 34 | 106 |
| 2022 5 | 52 | 38 | 90 |
| 2022 4 | 56 | 39 | 95 |
| 2022 3 | 66 | 47 | 113 |
| 2022 2 | 48 | 41 | 89 |
| 2022 1 | 46 | 29 | 75 |
| 2021 12 | 55 | 40 | 95 |
| 2021 11 | 47 | 34 | 81 |
| 2021 10 | 49 | 45 | 94 |
| 2021 9 | 55 | 26 | 81 |
| 2021 8 | 39 | 29 | 68 |
| 2021 7 | 58 | 30 | 88 |
| 2021 6 | 29 | 19 | 48 |
| 2021 5 | 38 | 22 | 60 |
| 2021 4 | 84 | 47 | 131 |
| 2021 3 | 63 | 19 | 82 |
| 2021 2 | 77 | 17 | 94 |
| 2021 1 | 43 | 13 | 56 |
| 2020 12 | 35 | 4 | 39 |
| 2020 11 | 45 | 6 | 51 |
| 2020 10 | 33 | 14 | 47 |
| 2020 9 | 34 | 11 | 45 |
| 2020 8 | 49 | 5 | 54 |
| 2020 7 | 48 | 11 | 59 |
| 2020 6 | 58 | 4 | 62 |
| 2020 5 | 44 | 10 | 54 |
| 2020 4 | 41 | 12 | 53 |
| 2020 3 | 63 | 8 | 71 |
| 2020 2 | 57 | 11 | 68 |
| 2020 1 | 65 | 16 | 81 |
| 2019 12 | 49 | 12 | 61 |
| 2019 11 | 50 | 18 | 68 |
| 2019 10 | 39 | 12 | 51 |
| 2019 9 | 63 | 23 | 86 |
| 2019 8 | 32 | 11 | 43 |
| 2019 7 | 36 | 21 | 57 |
| 2019 6 | 27 | 5 | 32 |
| 2019 5 | 32 | 7 | 39 |
| 2019 4 | 78 | 23 | 101 |
| 2019 3 | 30 | 7 | 37 |
| 2019 2 | 32 | 20 | 52 |
| 2019 1 | 40 | 12 | 52 |
| 2018 12 | 72 | 25 | 97 |
| 2018 11 | 54 | 11 | 65 |
| 2018 10 | 52 | 7 | 59 |
| 2018 9 | 39 | 9 | 48 |
| 2018 8 | 32 | 10 | 42 |
| 2018 7 | 34 | 7 | 41 |
| 2018 6 | 19 | 10 | 29 |
| 2018 5 | 33 | 10 | 43 |
| 2018 4 | 24 | 6 | 30 |
| 2018 3 | 28 | 5 | 33 |
| 2018 2 | 35 | 5 | 40 |
| 2018 1 | 27 | 9 | 36 |
| 2017 12 | 33 | 8 | 41 |
| 2017 11 | 23 | 5 | 28 |
| 2017 10 | 36 | 12 | 48 |
| 2017 9 | 38 | 18 | 56 |
| 2017 8 | 52 | 11 | 63 |
| 2017 7 | 50 | 7 | 57 |
| 2017 6 | 32 | 8 | 40 |
| 2017 5 | 38 | 5 | 43 |
| 2017 4 | 23 | 7 | 30 |
| 2017 3 | 22 | 6 | 28 |
| 2017 2 | 33 | 12 | 45 |
| 2017 1 | 14 | 15 | 29 |
| 2016 12 | 37 | 5 | 42 |
| 2016 11 | 34 | 7 | 41 |
| 2016 10 | 62 | 7 | 69 |
| 2016 9 | 57 | 1 | 58 |
| 2016 8 | 74 | 4 | 78 |
| 2016 7 | 107 | 5 | 112 |
| 2016 6 | 116 | 0 | 116 |
| 2016 5 | 114 | 0 | 114 |
| 2016 4 | 67 | 0 | 67 |
| 2016 3 | 67 | 0 | 67 |
| 2016 2 | 61 | 0 | 61 |
| 2016 1 | 71 | 0 | 71 |
| 2015 12 | 89 | 0 | 89 |
| 2015 11 | 83 | 0 | 83 |
| 2015 10 | 79 | 0 | 79 |
| 2015 9 | 54 | 0 | 54 |
| 2015 8 | 65 | 0 | 65 |
| 2015 7 | 52 | 0 | 52 |
| 2015 6 | 34 | 0 | 34 |
| 2015 5 | 43 | 0 | 43 |
| 2015 4 | 9 | 0 | 9 |
Show all
